Clinical trial

The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection

NCT05380999

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-05-01

PhaseN/A

Study timeline

Study start (estimated)2022-05-01Date precision: month

Registry last updated2022-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Red Blood Cellsunresolved

Methylationunresolved

Interventions

Methylation tests of nucleic acids extracted from mature red blood cells (RBCs)DIAGNOSTIC_TEST

Sponsors & collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoollead sponsor

Peking Union Medical College Hospitalcollaborator

Shanghai Chest Hospitalcollaborator

Guangzhou Panyu Central Hospitalcollaborator

My-BioMed Technology （Guangzhou） Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05380999 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.